Uploaded November 2025 | Updated November 2026, 3 hours ago
Particle accelerators aren’t just for studying the universe — they're also driving breakthroughs in medicine!
Brookhaven is one of three national labs leveraging its accelerator infrastructure to produce actinium-225, a rare medical isotope that shows great promise for treating cancer.
This accelerator-produced actinium-225 will be used to treat human patients for the first time ever in a groundbreaking clinical trial beginning this year.
Particle accelerators aren’t just for studying the universe — they're also driving breakthroughs in medicine!
Brookhaven is one of three national labs leveraging its accelerator infrastructure to produce actinium-225, a rare medical isotope that shows great promise for treating cancer.
This accelerator-produced actinium-225 will be used to treat human patients for the first time ever in a groundbreaking clinical trial beginning this year.










